ATMP manufacturers must ensure compliance with these guidelines no later than 22 May 2018. The guidelines seek to reflect the rapid technological and medical advancements being made in the field of ATMPs (i.e. gene therapies, somatic cell therapies and tissue engineered products), such as decentralised manufacturing for autologous products ...
EMA Quality Guideline for Biologics IMPDs have been used as a basis, IMPD guideline and template. This guide assumes that CTD sections 3.2.S (drug substance) and 3.2.P (drug product) will be authored. To enable efficient authoring, it is helpful if a decision has been made where drug substance manufacture
Assistant scientific coordinator for EU-H2020-funded ATMP/GMP projects at the BIH Center for Regenerative Therapies (BCRT) - Charité University Medicine Berlin. Prior PhD and PostDoc studies on improving the safety and efficacy of MSC therapies at Karolinska Institutet in Stockholm Sweden, and diploma studies of effector T-cell therapies at ...
ATMP Challenges in the EU; Approval times of anti-cancer Drugs; Geriatric Regulation; Old Medicines, New Indications; Orphan Drug Designation in the EU and US; Post-authorisation Studies; Preclinical requirements for anticancer drugs in the EU
Palindromic numbers